Actus Biotechnologies Inc Tucson, AZ - 85704

Actus Biotechnologies Inc is categorized under Biological Products Manufacturers in Tucson, AZ and active since 2011.

Actus Biotechnologies Inc was established in 2011, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Dr John Muraski Phd at the company’s headquarters by writing to 405 West Cool Drive # 107, Tucson, Arizona AZ 85704 or by phoning (702) 448-1826. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Actus Biotechnologies Inc
Contact Person: Dr John Muraski Phd
Address: 405 West Cool Drive # 107, Tucson, Arizona 85704
Phone Number: (702) 448-1826
Website Address: actusbiotech.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Products Manufacturers
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Actus Biotechnologies Inc was started in 2011 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Dr John Muraski Phd for inquiries that concern Actus Biotechnologies Inc by calling the company number (702) 448-1826, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Actus Biotechnologies Inc can be found at the coordinates as well as the street address 405 West Cool Drive # 107 in Tucson, Arizona 85704.

For its online presence, you may visit Actus Biotechnologies Inc’s website at actusbiotech.com and engage with its social media outlets through on Twitter and on Facebook.